139 related articles for article (PubMed ID: 8723512)
1. Relevance of the determination of ovarian volume in adolescent girls with menstrual disorders.
Herter LD; Magalháes JA; Spritzer PM
J Clin Ultrasound; 1996 Jun; 24(5):243-8. PubMed ID: 8723512
[TBL] [Abstract][Full Text] [Related]
2. Association of ovarian volume and serum LH levels in adolescent patients with menstrual disorders and/or hirsutism.
Herter LD; Magalhães JA; Spritzer PM
Braz J Med Biol Res; 1993 Oct; 26(10):1041-6. PubMed ID: 8312836
[TBL] [Abstract][Full Text] [Related]
3. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
4. Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence.
Avvad CK; Holeuwerger R; Silva VC; Bordallo MA; Breitenbach MM
Gynecol Endocrinol; 2001 Jun; 15(3):170-7. PubMed ID: 11447727
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.
Sikka P; Gainder S; Dhaliwal LK; Bagga R; Sialy R; Sahdev S
Int J Fertil Womens Med; 2007; 52(1):41-7. PubMed ID: 17987887
[TBL] [Abstract][Full Text] [Related]
6. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
[TBL] [Abstract][Full Text] [Related]
7. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian hyperandrogenism in adolescent girls with menstrual disorders].
Małecka-Tendera E; Zachurzok A; Wrześniewski N; Kurkowska M
Ginekol Pol; 2002 Feb; 73(2):93-101. PubMed ID: 12001778
[TBL] [Abstract][Full Text] [Related]
9. Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents.
Dramusic V; Goh VH; Rajan U; Wong YC; Ratnam SS
J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):125-32. PubMed ID: 9288656
[TBL] [Abstract][Full Text] [Related]
10. On the relationship between endocrine and ovulatory abnormalities, and polycystic ovaries as diagnosed by ultrasonography.
Takahashi K; Yoshino K; Nishigaki A; Eda Y; Kitao M
Int J Fertil; 1992; 37(4):222-6. PubMed ID: 1354209
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
12. [Ultrasound criterion for the diagnosis of polycystic ovary syndrome: ovarian stroma/total area ratio].
Qiu Y; Liu J; Zhou YF; Gui WW; Liu SW; Wang FL; Zhang HY; Ma Z
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):595-7. PubMed ID: 15498185
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
14. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio.
Fulghesu AM; Ciampelli M; Belosi C; Apa R; Pavone V; Lanzone A
Fertil Steril; 2001 Aug; 76(2):326-31. PubMed ID: 11476780
[TBL] [Abstract][Full Text] [Related]
15. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome.
Takahashi K; Eda Y; Abu-Musa A; Okada S; Yoshino K; Kitao M
Hum Reprod; 1994 Jul; 9(7):1231-6. PubMed ID: 7962423
[TBL] [Abstract][Full Text] [Related]
16. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
[TBL] [Abstract][Full Text] [Related]
17. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Morphology by Transabdominal Ultrasound Correlates With Reproductive and Metabolic Disturbance in Adolescents With PCOS.
Rackow BW; Vanden Brink H; Hammers L; Flannery CA; Lujan ME; Burgert TS
J Adolesc Health; 2018 Mar; 62(3):288-293. PubMed ID: 29217212
[TBL] [Abstract][Full Text] [Related]
19. Hormone profile & polycystic ovaries in acne vulgaris.
Jebraili R; Kaur S; Kanwar AJ; Kataria S; Dash RJ
Indian J Med Res; 1994 Aug; 100():73-6. PubMed ID: 7927560
[TBL] [Abstract][Full Text] [Related]
20. Hormonal effects of flutamide in young women with polycystic ovary syndrome.
De Leo V; Lanzetta D; D'Antona D; la Marca A; Morgante G
J Clin Endocrinol Metab; 1998 Jan; 83(1):99-102. PubMed ID: 9435423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
